164 related articles for article (PubMed ID: 32933805)
1. Continuing controversy regarding individualized surgical decision-making for patients with 1-4 cm low-risk differentiated thyroid carcinoma: A systematic review.
Liu W; Yan X; Cheng R
Eur J Surg Oncol; 2020 Dec; 46(12):2174-2184. PubMed ID: 32933805
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
[TBL] [Abstract][Full Text] [Related]
3. Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model.
Kebebew E; Duh QY; Clark OH
World J Surg; 2000 Nov; 24(11):1295-302. PubMed ID: 11038197
[TBL] [Abstract][Full Text] [Related]
4. Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer: Is Total Thyroidectomy Necessary for Patients at Any Risk?
Sugino K; Nagahama M; Kitagawa W; Ohkuwa K; Uruno T; Matsuzu K; Suzuki A; Tomoda C; Hames KY; Akaishi J; Masaki C; Ito K
Thyroid; 2020 Apr; 30(4):548-556. PubMed ID: 31910105
[No Abstract] [Full Text] [Related]
5. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.
Takami H; Ito Y; Okamoto T; Yoshida A
World J Surg; 2011 Jan; 35(1):111-21. PubMed ID: 21042913
[TBL] [Abstract][Full Text] [Related]
6. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
7. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
[TBL] [Abstract][Full Text] [Related]
8. Lobectomy Compared to Total Thyroidectomy for Low-Risk Papillary Thyroid Cancer: A Systematic Review.
Vargas-Pinto S; Romero Arenas MA
J Surg Res; 2019 Oct; 242():244-251. PubMed ID: 31103828
[TBL] [Abstract][Full Text] [Related]
9. Thyroid surgery for differentiated thyroid cancer - recent advances and future directions.
Wang TS; Sosa JA
Nat Rev Endocrinol; 2018 Nov; 14(11):670-683. PubMed ID: 30131586
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
[TBL] [Abstract][Full Text] [Related]
11. Impact of Extent of Surgery on Tumor Recurrence and Survival for Papillary Thyroid Cancer Patients.
Gartland RM; Lubitz CC
Ann Surg Oncol; 2018 Sep; 25(9):2520-2525. PubMed ID: 29855833
[TBL] [Abstract][Full Text] [Related]
12. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
[TBL] [Abstract][Full Text] [Related]
13. The impact of completion thyroidectomy.
Sawant R; Hulse K; Sohrabi S; Yeo JCL; Pal K; Gibb FW; Adamson R; Nixon IJ
Eur J Surg Oncol; 2019 Jul; 45(7):1171-1174. PubMed ID: 30910458
[TBL] [Abstract][Full Text] [Related]
14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
15. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategy for low-risk thyroid cancer in Kanaji Thyroid Hospital.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Yamada T
Endocr J; 2014; 61(1):1-12. PubMed ID: 24067543
[TBL] [Abstract][Full Text] [Related]
17. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
Lang BH; Wong CKH
Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
[TBL] [Abstract][Full Text] [Related]
18. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
Macedo FI; Mittal VK
Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
[TBL] [Abstract][Full Text] [Related]
19. Can we really consider tumor size and surgical extent as predictive factors for recurrence in clinically early-stage papillary thyroid carcinoma patients?
Khosravi MH
Am J Surg; 2016 Nov; 212(5):1030-1031. PubMed ID: 27522561
[No Abstract] [Full Text] [Related]
20. Cervical soft tissue recurrence of differentiated thyroid carcinoma after thyroidectomy indicates a poor prognosis.
Gao L; Jiang Y; Liang Z; Zhang L; Mao X; Yang X; Wang Y; Xu J; Liu R; Zhu S; Zhao R; Lai X; Zhang X; Zhang B
Int J Surg; 2017 Dec; 48():254-259. PubMed ID: 28919092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]